Diamens
PrivateLast Round
Pre Seed
Mar 17, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Diamens is a healthtech company developing a non-invasive, at-home molecular diagnostic test for endometriosis using menstrual blood.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diamens Comparables
Compare Diamens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| theblood | 87% | |
| DotLab | 77% | |
| Hera Biotech | 77% | |
Diamens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 17, 2026 |
Diamens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQventure | Pre Seed |
| VP Venture Partners | Pre Seed |
| FS Life Science Investment | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
EQventure led the round with FS Life Science Investment and VP Venture Partners.
- Jan 25, 2025
Monthly visitors increased 58% MoM, from 1.9K to 3K.
Diamens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Diamens's valuation, stock price, and market status.